Business
Accuracy of HER2 Testing in Gastric Cancer
- Anatomic Pathology
- Business
- Clinical Laboratories
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Genetics
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Medical Research
- Pathology News
- Patient Advocacy
- Science
- Standards and Guidelines
- Training
- Vendor products
- Web/Tech
- Webinars
- Whole slide
With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab...
The growing healthcare needs in North America have created a number of challenges for modern pathology practices such as limited capacity for slide storage, reduced access to specialist expertise, and increased workload and budget constraints....
New Omnyx-Clarient alliance enables collaboration in the cancer diagnosis process, empowers personalized therapeutics PITTSBURGH and ALISO VIEJO, CA, March 24, 2015 — Amidst an estimated 70 percent increase in cancer diagnosis in...
Omnyx, LLC, the digital pathology joint venture between University of Pittsburgh Medical Center (UPMC) and GE Healthcare, today announced a memorandum of understanding with Argent Global Services, a process engineering and management consulting...
Originally published March 11, 2015 By Simon Häger, Product Manager, Sectra Digital Pathology Solution Multi-Disciplinary Team Meetings (MDT) are a cornerstone of cancer care. Several recent studies [1-3] clearly demonstrate that MDTs, or...
After thorough testing, and internal clinical validation, Herlev University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization...